|
Market Closed -
Toronto S.E.
15:22:37 2026-09-10 EDT
|
5-day change | 1st Jan Change | ||
| 0.0600 CAD | +20.00% |
|
-.--% | -40.00% |
| Market Cap | 337K 241K 215K 198K 180K 22.85M 344K 2.36M 952K 12.06M 906K 887K 38.09M | P/E 2024 * |
-
| P/E 2025 | -2.96x |
|---|---|---|---|---|---|
| Enterprise Value | 337K 241K 216K 198K 180K 22.85M 344K 2.36M 952K 12.06M 906K 887K 38.1M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
59.29% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +20.00% | ||
| 3 months | -25.00% | ||
| Current year | -40.00% |
| Current year | 0.05 | 0.1 | |
| 1 year | 0.05 | 0.1 | |
| 3 years | 0 | 0.1 | |
| 5 years | 0 | 0.14 | |
| 10 years | 0 | 0.33 |
| Manager | Title | Age | Since |
|---|---|---|---|
Harry Katevatis
CEO | Chief Executive Officer | 84 | 2019-03-10 |
| Director | Title | Age | Since |
|---|---|---|---|
Harry Katevatis
BRD | Director/Board Member | 84 | 2019-03-10 |
Vivian Katsuris
BRD | Director/Board Member | 61 | 2019-03-14 |
| Director/Board Member | 62 | 2024-06-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/7/20 | NGN Biomed Opportunity II LP
| Sell | Company | 125,000 | 2.7778% | |
| 5/7/20 | NGN Biomed Opportunity II LP
| Other | Company | 0 | 0% | - |
| 5/7/20 | NGN Biomed Opportunity II LP
| Sell | Company | 25,000 | 0.5556% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +20.00% | -.--% | +20.00% | -42.86% | 181K | ||
| -0.44% | +0.02% | +32.41% | +102.77% | 133B | ||
| -0.10% | +0.39% | +31.43% | +76.07% | 23.1B | ||
| -1.05% | +0.59% | +24.38% | +54.28% | 17.32B | ||
| -2.78% | +3.43% | +17.19% | +152.93% | 15.49B | ||
| +0.17% | +0.95% | +16.06% | +26.00% | 14.89B | ||
| +0.84% | +2.13% | -7.40% | +7.26% | 14.31B | ||
| +1.89% | +1.53% | +21.88% | +35.08% | 12.13B | ||
| +0.04% | -4.46% | -14.65% | +49.56% | 12.19B | ||
| -0.52% | -4.07% | +49.61% | +63.60% | 11.47B | ||
| Average | +1.79% | +0.86% | +19.09% | +52.47% | 25.39B | |
| Weighted average by Cap. | -0.35% | +1.61% | +25.66% | +82.66% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -184K -132K -118K -108K -98.37K -12.5M -188K -1.29M -521K -6.6M -495K -485K -20.83M | -71.29K -51.02K -45.55K -41.8K -38.02K -4.83M -72.71K -499K -201K -2.55M -191K -187K -8.05M |
| Net Debt | -6.67K -4.78K -4.26K -3.91K -3.56K -452K -6.81K -46.73K -18.84K -239K -17.92K -17.54K -754K | 68 48.67 43.45 39.87 36.27 4.61K 69.35 476.23 191.97 2.43K 182.65 178.76 7.68K |
Employees
-
Sector
Investment Holding Companies
- Stock Market
- Stocks
- ZENI.P Stock
Select your edition
All financial news and data tailored to specific country editions
















